Physician profile
Blake Burkert
NPI 1205248713
$2,777.70
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $709 · 2021: $676 · 2022: $144 · 2023: $205 · 2024: $882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $625 · Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $625.00 |
| Food and Beverage | $462.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,137.53 | 2019-2021 | |
| Bioventus LLC | $625.00 | 2024 | Nexus-10 Mkii |
| Nalu Medical, INC. | $441.28 | 2023-2024 | Nalu Neurostimulation System |
| Depuy Synthes Sales INC. | $155.35 | 2020 | |
| Boston Scientific Corporation | $117.65 | 2022 | |
| Misonix INC | $105.68 | 2020 | |
| Vertos Medical, INC. | $72.91 | 2021 | |
| Djo, LLC | $63.49 | 2021 | |
| Seaspine Orthopedics Corporation | $26.57 | 2022 | |
| Sanara Medtech INC. | $20.73 | 2024 | Celleraterx |
| Axogen | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Burkert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.